RBC Capital Downgrades Concordia Healthcare (CXRX) to Sector Perform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/19/2026
- US stock futures steady after tech slump; investors focus on Middle East tensions
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- U.S. debt tops $40 trillion
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Marvell issues Google warrant tied to custom chip deal
- Tech selloff weighs down Wall Street as bond yields climb
- FOMC minutes from July 28-29th meeting
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- US stock futures steady after tech slump; investors focus on Middle East tensions
Canaccord Genuity Downgrades Concordia Healthcare (CXRX) to Sell
November 7, 2016 1:24 PM ESTCanaccord Genuity downgraded Concordia Healthcare (NASDAQ: CXRX) from Spec. Buy to Sell with a price target of $1.00.
For an analyst ratings summary and ratings history on Concordia Healthcare click here. For more ratings news on Concordia Healthcare click here.
Shares of Concordia Healthcare closed at $3.19 yesterday.
... MoreConcordia International (CXRX) Misses Q3 EPS by 35c; Guidance Suspended
November 7, 2016 7:06 AM ESTConcordia International (NASDAQ: CXRX) reported Q3 EPS of $0.69, $0.35 worse than the analyst estimate of $1.04. Revenue for the quarter came in at $185.5 million versus the consensus estimate of $206 million.
Concordia is suspending guidance as the Company assesses the business under new leadership
The Company commented, "Concordia's... More
